SF3B1-mutant CMML defines a predominantly dysplastic CMML subtype with a superior acute leukemia-free survival.
暂无分享，去创建一个
A. Tefferi | M. Patnaik | E. Padron | T. Lasho | S. Loghavi | R. Komrokji | A. Al-Kali | C. Finke | N. Gangat | K. Reichard | A. Mangaonkar | K. Wudhikarn | M. Binder | M. Howard | R. Ketterling | N. Ali | R. Carr | Ryan M. Carr